Skip to main navigation Skip to search Skip to main content

C19: ACTIV 4C: A multicenter, adaptive, prospective, randomized trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge

Project: Research

Project Details

StatusFinished
Effective start/end date04/1/2103/31/23

Funding

  • National Heart Lung and Blood Institute: $37,500.00